Sidley represented Nova Labs, Inc. on the deal. Nova Labs, Inc., a pioneer of decentralized wireless communications that launched the core technologies powering the Helium Network,...
Nova Labs’ Acquisition of FreedomFi
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Tempest Therapeutics’ Merger With Millendo Therapeutics
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
Tempest Therapeutics’ Merger With Millendo Therapeutics
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...